Your browser doesn't support javascript.
loading
Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy.
Schmidt, Rose A.
Affiliation
  • Schmidt RA; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Addiction ; 117(6): 1818-1819, 2022 06.
Article in En | MEDLINE | ID: mdl-35129228
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Opioid-Related Disorders Type of study: Risk_factors_studies Limits: Female / Humans / Pregnancy Language: En Journal: Addiction Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Opioid-Related Disorders Type of study: Risk_factors_studies Limits: Female / Humans / Pregnancy Language: En Journal: Addiction Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United kingdom